Also inside: Why this company could gain 260% after its earnings were “the best ever by a Canadian cannabis company.”

Plus: Five mid-cap growth stocks from Morningstar.

Also inside: Ways to gird for a downturn with sturdy, non-cyclical, defensive names.

Also inside: Nicely pedigreed gold spinoff is well-located and well-backed.

Plus: Major deal catalyst can help this company finally deliver on its promise.

Also inside: This outperforming, non-Canada focused oil company can gain another 44% after rising nearly 70% in the last five years.

Also inside: Why this producer is the best way to trade silver’s resurgence.

Plus: Blue chip partners and biotech background gives this newly-public cannabis company an edge.

Also inside: CanTech Newsletter Founder & Editor Nick Waddell rounds up nine top tech & healthcare picks.

Plus: Spartan MM Fund’s Ed Sollbach updates his 2019 best idea.

Also inside: Major societal shift can propel this cover story to another 26% gain.

Plus: Why these stocks are indicating technical breakouts. 

Also inside: Mid-Year Report Card shows lots of double digit winners.

Plus: This former turnaround gaining traction with 34% upside.